
Research Peptides
An investigational triple GIP, GLP-1 and glucagon receptor agonist studied in metabolic research.
Retatrutide (LY3437943) is an investigational single peptide that acts as an agonist at three receptors: GIP, GLP-1 and glucagon. This "triple agonist" design makes it a compound of major interest in metabolic and endocrine research.
Retatrutide is still in clinical development and is not an approved medicine. Vanguard Labs supplies it strictly as a reference material for in-vitro research.
Independently tested by accredited labs for identity, purity and/or concentration. See our quality control process.
Supplied as a lyophilized (freeze-dried) powder. Store at -20°C away from light; once reconstituted, keep refrigerated at 2-8°C.
Sold strictly for in-vitro laboratory research. Not for human consumption, veterinary or diagnostic use.
All orders ship locally from within Ireland, with delivery in 3-5 business days. To order Retatrutide, use the live chat or our contact page. Have a question? Read our FAQ, or pick up bacteriostatic water for reconstitution.